Cancer chemotherapy is the use of drugs to destroy cancer cells. Chemotherapy is usually prescribed by oncologists (physicians with advanced training in treatment of cancer). The June 11, 2008, issue of JAMA includes an article assessing the difficult decisions cancer patients and their doctors must make about the use and extent of chemotherapy as patients near the end of life.
The type of cancer, what organs are affected, age, health, and the goals and adverse effects of treatment are important issues. One of the most important issues is your "performance status," rated on the following scale. Patients with a performance status of 3 or 4 usually should not receive chemotherapy because they will have little chance of benefit and more adverse effects.
0 Fully active
1 Restricted in physically strenuous activity but ambulatory (able to walk) and able to carry out work of a light or sedentary nature, such as light housework or office work
2 Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours
3 Capable of only limited self-care; confined to bed or chair more than 50% of waking hours
4 Completely disabled; cannot carry on any self-care; totally confined to bed or chair
Treatment
• What is my performance status?
• What is my chance of cure?
• What is the chance that this chemotherapy will make my cancer shrink?
• Will I live longer with chemotherapy? How much longer?
• What are the main adverse effects of the chemotherapy?
• Will I feel better or worse from the chemotherapy?
• Are there nonchemotherapy options such as hospice or palliative care?
• Are there clinical trials available?
• What are the benefits?
• Am I eligible?
• What is needed to enroll?
Prognosis
• What are the likely things that will happen to me?
• How long will I live? (Ask for a range, and the most likely scenario for the period ahead, and when death might be expected.)
• Are there other things I should be doing?
• Will
• Advance directives
• Durable attorney for health care (Who can speak for me if I am unable?)
• Financial or legal issues
• Family issues (Will you help me talk with my family?)
• Spiritual and psychological issues (Who is available to help me cope with this situation?)
• Legacy and life review (What do I want to pass on to my family about my life?)
American Cancer Society http://www.cancer.org
National Cancer Institute http://www.cancer.gov
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on clinical trials was published in the June 9, 2004, issue; and one on radiation therapy was published in the September 14, 2005, issue.
Sources: American Cancer Society, National Cancer Institute
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: CANCER
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.